Clinical Trial Update: Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update notes an adjunctive therapy with Andrographolid Sulfonatein for community-acquired pneumonia, sponsored by Qingfeng Pharmaceutic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Andrographolid Sulfonatein

Snippet

Sponsor: Qingfeng Pharmaceutical Group | Conditions: Community Acquired Pneumonia | Phase 4 | Status: UNKNOWN